CVE-2020-16198

Philips Clinical Collaboration Platform Protection Mechanism Failure

Description

When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct.

Remediation

Solution:

  • Philips Clinical Collaboration Platform Version 12.2.5 was released in May 2020 to remediate CVE-2020-16198. Users with questions regarding their specific Philips Clinical Collaboration Platform installations and new release eligibility should contact Philips service support, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-877-328-2808, option 4. The Philips advisory and the latest security information for Philips products are available at the Philips product security website https://www.philips.com/productsecurity .

Category

5.0
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.06%
Third-Party Advisory cisa.gov
Affected: Philips Clinical Collaboration Platform
Published at:
Updated at:

References

Link Tags
https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01 us government resource third party advisory
https://www.philips.com/a-w/security/security-advisories/product-security-2020.html#2020_archive

Frequently Asked Questions

What is the severity of CVE-2020-16198?
CVE-2020-16198 has been scored as a medium severity vulnerability.
How to fix CVE-2020-16198?
To fix CVE-2020-16198: Philips Clinical Collaboration Platform Version 12.2.5 was released in May 2020 to remediate CVE-2020-16198. Users with questions regarding their specific Philips Clinical Collaboration Platform installations and new release eligibility should contact Philips service support, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-877-328-2808, option 4. The Philips advisory and the latest security information for Philips products are available at the Philips product security website https://www.philips.com/productsecurity .
Is CVE-2020-16198 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-16198 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-16198?
CVE-2020-16198 affects Philips Clinical Collaboration Platform.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.